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Seborrheic Keratosis: A Hotbed of Mutations
Hafner and colleagues analyzed 78 SK from 
four patients to determine the spectrum of 
fibroblast growth factor receptor 3 (FGFR3) 
mutations in seborrheic keratoses (SK). FGFR3 
mutations were detected in 46 of 78 SK (59 %). 
The mutation rates of the patients ranged from 
26% to 89%, and each patient showed at least 
four different mutated loci. FGFR3 mutations 
appear to be common genetic alterations in 
multiple SK with a varying interindividual 
mutation frequency but without specific intraindividual hot spots. See page 1883 
Thromboxane A2 in Pruritis
When Andoh et al. gave mice an intradermal injec-
tion of U-46619, a stable analogue of thromboxane 
A2 (TXA2), the mice began scratching. TXA2 exerts its 
action through a G-protein-coupled receptor called 
TP. U-46619’s action was inhibited by a co-injection 
of the TP antagonist ONO-3708 and was abolished 
by TP receptor deficiency. The results suggest that 
TXA2 acts as an itch mediator through the activation 
of TP receptors on primary afferents and keratino-
cytes. Thus, thromboxane synthase inhibitors and TP 
receptor antagonists may become useful as antipru-
ritic agents. See page 2042 
Difficult to Keep Kids Out of the Sun
Naldi and colleagues conduct-
ed a 3-year cluster random-
ized trial of an educational 
intervention to reduce sunburn 
rates and improve sun protec-
tion behavior in schoolchil-
dren. Children in 122 Italian 
schools were randomized as 
to whether they would receive 
a short video and booklets for 
children and parents. Of 8,611 
children who completed the 
study, 14% reported a his-
tory of sunburns at baseline; 
at follow-up, no difference in 
sunburn episodes was docu-
mented between the groups and similar sun protection habits were reported. Future 
programs might target more susceptible subgroups and those people who are less 
likely to practice recommended behavior. See page 1871
Involucrin Degrades 
in HH
To study how ATP2C1 
function impacts keratinocyte 
differentiation, Aberg and co-
workers assessed involucrin 
protein expression in 
Hailey–Hailey disease (HHD) 
keratinocytes. Although 
involucrin is ordinarily 
expressed in response to 
increased intracellular Ca2+ 
concentrations, the authors 
determined that HHD 
keratinocytes expressed 
lower involucrin levels 
than controls at both low 
and high extracellular Ca2+ 
concentrations. Decreased 
involucrin protein levels were 
caused by lower involucrin 
mRNA levels in HHD 
keratinocytes. These are new 
insights into differentiation 
defects in HHD and its 
relationship to Ca2+ signaling. 
See page 1973 
Serotonin, the 
Activator
Soga and co-workers 
investigated the 
effects of serotonin (5-
hydroxytryptamine, 5-HT) 
on the function and life span 
of monocytes and 5-HT’s 
contribution to the chronicity 
of atopic dermatitis (AD). 
Plasma levels of 5-HT were 
increased in AD patients and 
5-HT activated monocytes 
and prevented monocytic 
apoptosis via 5-HTR1 and/or 
5-HTR7 receptors. These 
effects may contribute to 
the establishment of chronic 
lesions and provide new 
insight into the pathogenic 
relationship between the cells 
and platelets in AD. See page 
1947 
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